Insect Acetylcholinesterase Crystallization via Segmentation and Tagging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for creating crystals of insect acetylcholinesterase, particularly those with mutations like the G280S mutation, are inadequate for X-ray crystallography, leading to ineffective modeling and the rise of insecticide-resistant strains.

Innovation Solution

A method involving the creation of recombinant DNA constructs with a targeted catalytic core sequence and polyhistidine tag, followed by expression in insect cells, purification, and crystallization, enables the production of crystals suitable for X-ray crystallography, including those with specific mutations like G280S.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to create crystals of insect acetylcholinesterase, then the process is simpler, but the crystals are inadequate for X-ray crystallography and cannot accurately model resistant strains

Engineering Contradiction:
Improvecrystal quality for X-ray crystallographyVSAvoidcomplexity of crystal creation method
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The catalytic core sequence is segmented from the full-length acetylcholinesterase gene, isolating only the essential region (codons 162-702) that contains the active site. This segmentation allows the crystal structure to focus on the functionally critical region, improving diffraction quality while reducing structural complexity that would interfere with X-ray analysis.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A polyhistidine tag is introduced as an intermediary element at the N-terminus of the catalytic core sequence. This tag serves as a mediator that facilitates purification through affinity chromatography and potentially aids in crystal packing, enabling the production of high-quality crystals suitable for X-ray crystallography without requiring complex purification protocols.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If insecticides are widely applied to control insect populations, then pest control effectiveness improves, but insecticide-resistant strains develop through mutations

Engineering Contradiction:
Improvepest control effectivenessVSAvoidinsecticide resistance development
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention creates crystal structures of acetylcholinesterase with predetermined insecticide-resistant mutations (such as G280S) before conducting structural analysis. This preliminary incorporation of mutant sequences allows researchers to study the structural basis of resistance mechanisms in advance, enabling the design of next-generation insecticides that can overcome known resistance pathways before they become widespread problems.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If the full-length acetylcholinesterase sequence is used for crystallization, then the protein maintains complete biological function, but crystal formation is inadequate for high-resolution structural analysis

Engineering Contradiction:
Improveresolution of crystal structureVSAvoidprotein sequence length
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The invention extracts and isolates only the catalytic core sequence (codons 162-702) from the full-length acetylcholinesterase gene for crystallization. This extraction removes non-essential regions that would interfere with crystal packing and diffraction quality, while preserving the complete catalytic functionality needed for studying enzyme-inhibitor interactions and resistance mechanisms.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for accurate modeling of insect acetylcholinesterase crystals, including resistant strains, facilitating the study of insecticides and their effects, and providing high-resolution digital models.

Implementation Method 1

The polyhistidine tag is utilized to purify the secreted polypeptide by passing a solution containing the polypeptide over a column containing Ni-NTA agarose

Methodology Applied
Scientific EffectAffinity chromatography: Chromatography

Implementation Method 2

X-ray crystallography is a method used for determining the atomic and molecular structure of a crystal, in which the crystalline atoms cause a beam of X-rays to diffract into many specific directions

Methodology Applied
Scientific EffectX-ray diffraction: X-Ray

Implementation Method 3

the crystalline atoms cause a beam of X-rays to diffract into many specific directions

Methodology Applied
Scientific EffectDiffraction: Diffraction

Implementation Method 4

The cell colonies package the DNA construct into a larger DNA construct that can be isolated. This larger DNA construct which contains the recombinant DNA can be used to produce a virus in insect cells

Methodology Applied
Scientific EffectViral transfection:

Data Source

PatentUS10683488B2System and method for creating crystals of insect acetylcholinesterase
Publication Date: 2020.06.16 NEW YORK STRUCTURAL BIOLOGY CENT
  • US10683488B2 patent drawing
  • US10683488B2 patent drawing
  • US10683488B2 patent drawing

AI summary

A method of creating crystals of insect acetylcholinesterase. A polynucleotide is obtained that encodes for acetylcholinesterase in a targeted insect. The polynucleotide contains a catalytic core sequence. A recombinant DNA construct is formed by adding a fusion protein and a polyhistidine tag to the catalytic core sequence. The recombinant DNA construct can be further modified by adding known mutations for resistance to insecticides. A growth medium is transfected with the recombinant DNA construct. A polypeptide encoded by the recombinant DNA construct is separated from the growth medium to form a concentrate. The polyhistidine tag is removed from the concentrate. The concentrate is exchanged into a buffer to create a buffered concentrate. Crystals, suitable for X-ray crystallography are then grown with the buffered concentrate.